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Abstract
Objective. To explore how European hospitals have implemented patient safety strategies (PSS) and evidence-based organization of
care pathway (EBOP) recommendations and examine the extent to which implementation varies between countries and hospitals.
Design. Mixed-method multilevel cross-sectional design in seven countries as part of the European Union-funded project
‘Deepening our Understanding of Quality improvement in Europe’ (DUQuE).
Setting and participants. Seventy-four acute care hospitals with 292 departments managing acute myocardial infarction (AMI), hip
fracture, stroke, and obstetric deliveries.
Main outcome measure. Five multi-item composite measures—one generic measure for PSS and four pathway-specific measures
for EBOP.
Results. Potassium chloride had only been removed from general medication stocks in 9.4–30.5% of different pathways wards and
patients were adequately identified with wristband in 43.0–59.7%. Although 86.3% of areas treating AMI patients had immediate
access to a specialist physician, only 56.0% had arrangements for patients to receive thrombolysis within 30 min of arrival at the
hospital. A substantial amount of the total variance observed was due to between-hospital differences in the same country for PSS
(65.9%). In EBOP, between-country differences play also an important role (10.1% in AMI to 57.1% in hip fracture).
Conclusions. There were substantial gaps between evidence and practice of PSS and EBOP in a sample of European hospitals
and variations due to country differences are more important in EBOP than in PSS, but less important than within-country varia-
tions. Agencies supporting the implementation of PSS and EBOP should closely re-examine the effectiveness of their current
strategies.
Keywords: patient safety, quality improvement, quality management, practice variations, appropriate healthcare, hospital care,
effectiveness
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Introduction
Evidence-based medicine and the implementation of patient
safety recommendations are considered two of the cornerstones
for improving clinical care outcomes [1]. Agencies such as the
National Institute for Health Care and Excellence (NICE) and
the Scottish Intercollegiate Guidelines Network (SIGN) in the
UK and the French Haute Autorité de Santé (HAS) have long-
standing clinical pathway guidelines including measures and
descriptors for the delivery of high-quality care based on the im-
plementation of evidence-based clinical recommendations and
organizational practices [2–4], such as access to 24/7 diagnostic
and intervention facilities and systems for triage and transfer to
a specialist unit.
International patient safety efforts include the Global Patient
Safety Alliance launched by the World Health Organization
(WHO) and the Health Care Quality Indicator Project led by the
Organization for Economic Co-operation and Development
(OECD) [5]. In Europe, the Safety Improvement for Patients in
Europe (SImPatIE) project established a common European vo-
cabulary and set of indicators and internal and external instru-
ments to improve safety in healthcare [6] and the European
Network for Patient Safety (EUNetPaS) created an umbrella
network of all European Union (EU) member states and stake-
holders to enhance collaboration in the field of patient safety [7].
Currently, the joint action on Patient Safety and Quality of Care
is identifying activities and tools for mutual learning among all
EU member states [8].
In recent decades, clinical managers have sought to adopt
the above recommendations and improve patient care through
system design, guidelines and protocols, adverse event (AE)
reporting, and risk management. There is, however, limited
evidence that the efforts undertaken have led to significant
improvements in compliance with evidence-based medicine or
reduction in AEs [9–12]. Another concern is the scarcity of in-
formation on the implementation of patient safety strategies
(PSS) and evidence-based organization of pathways (EBOP)
in European hospitals. Compliance with these best practices in
EU countries is also an important policy issue as the recent
EU directive on cross-border healthcare reinforces the rights
of citizens to seek care in another member state [13].
Our objectives are to describe the implementation of PSS
and EBOP in a sample of European hospitals and to explore
the extent to which individual countries, hospitals, and depart-
ment level effects explain the variations observed.
Methods
Setting
This study was conducted as part of the Deepening our
Understanding of Quality improvement in Europe (DUQuE)
research project, whose conceptual framework and design is
detailed elsewhere [14]. We performed a cross-sectional, multi-
level study in which patient-level measurements are nested in
hospital departments, which, in turn, are nested in hospitals in
seven European countries (Czech Republic, France, Germany,
Poland, Portugal, Spain, and Turkey). Thirty hospitals were ran-
domly selected in each country and of these, 12 were selected,
also randomly, for comprehensive data collection at department
and patient level (maximum of 84 hospitals). Pathway and
patient-level data were collected for four areas: acute myocardial
infarction (AMI), obstetric deliveries, hip fracture, and stroke.
Ethical approval was obtained from the Bioethics Committee of
the Catalan Health Department (Spain) and each country com-
plied with confidentiality issues according to national legislation
or country-specific standards of practice.
Measures used in the analysis
PSS were identified through a mapping process of patient safety
recommendations drawn from the WHO High 5s project [15],
the Joint Commission International Patient Safety Goals [16],
Required Organizational Practices from Accreditation Canada
[17], and guidelines from intergovernmental organizations such
as the Council of Europe [18], the Council of the European
Union [19], and the WHO (World Alliance on Patient Safety
program) [20]. Selection of PSS was based on the frequency of
mention in the reviewed documents and coverage of key safety
areas (infection control, medication, life support, AE reporting
systems, and security). Selection was also based on the under-
lying evidence that a patient safety practice prevents or reduces
AEs. Eleven PSS items were analyzed. Nine were common to
the four pathways (elimination of potassium chloride concen-
trate from ward stocks, use of wristband identification, needle
disposal boxes, hand hygiene promotion/reminders, alcohol-
based hand rubs, resuscitation flow charts, crash carts, AE
reporting systems, use of AE reports in department quality of
care evaluations) and two were specific to obstetric deliveries
(neonate identification and secure nursery access). We decided
not to analyze safe injection practices as this recommendation
was considered to be generally implemented in the countries
analyzed. EBOP items were derived from NICE quality stan-
dards and SIGN audit tools for the areas relevant to our study
[21–24]. Although specific EBOP recommendations differed
for the four areas, they followed a generic care pathway design
and included items related to admission, acute care, rehabilita-
tion (where appropriate), and discharge. The final measures
included 5–10 pathway-specific items (Tables 3 and 4) [25].
We assumed that hospital characteristics (size, ownership, and
teaching status) and extent of implementation of quality man-
agement (QM) systems at hospital level could influence the im-
plementation of PSS and EBOP at department level. In the
DUQuE project, hospital-level QM systems are assessed using
three measures: the QM Systems Index (QMSI) (having QM
systems in place), the QM Compliance Index (QMCI) (compli-
ance with Plan-Do-Check/Study-Act cycle), and the Clinical
Quality Implementation Index (CQII). The validation and
results of these measures are reported elsewhere [26, 27].
Data collection
Data on PSS, EBOP, QMSI, and CQII were gathered during a
1.5-day onsite audit with visits to all clinical areas, including
emergency rooms, contemplated in this study. The audits were
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performed by external auditors (14 in total) with experience in
quality and safety management and hospital accreditation and
no relationship with the hospital in question. A centralized
‘teach the teacher’ session was carried out with leading auditors
to unify the implementation of the external assessment tool.
Training included theoretical and practical information, instruc-
tions on the main aspects to be assessed, and scoring guidance.
All items included in PSS and EBOP were assessed by direct
observation and rated on a five-point-Likert scale ranging from
‘no or negligible compliance’ (score 0) to ‘full compliance’
(score 4). Explicit criteria were developed to rank each of these
positions for each item. Data were collected between May 2011
and February 2012.
Statistical analysis
We used univariate and bivariate statistics to report the imple-
mentation of PSS and EBOP. Descriptive tables show the
number and percentage of departments rated as fully compliant
(≥90%) for each item. In order to report the country range for
each item, we calculated the percentage of hospitals in each
country reported being fully compliant for each item. The
country range shows the minimum and maximum of this value
across the seven countries included in our analysis. We com-
puted an overall score from the mean score for all items on each
specific scale to be used in the multilevel regression models.
We used multivariable adjusted linear mixed models to de-
compose the outcome variance for PSS and EBOP at each
pathway. The model for PSS included two random intercepts
for country and hospitals nested within country to account for
clustering of hospitals within countries and clustering of the
four pathways within hospitals. This allowed us to estimate
between-country, between-hospital, and within-hospital var-
iances. The PSS model also included fixed effects for pathway,
hospital characteristics (ownership, hospital size, and teaching
status), and QM measures at hospital level (QMSI, QMCI,
and CQII). A second set of models stratified by pathway were
also used to estimate the contribution of between-country and
within-country variances to the total variance of EBOP. These
models included a random intercept by country to account for
clustering of hospitals within countries and fixed effects for
hospital characteristics (ownership, hospital size, and teaching
status) and QM measures at hospital level (QMSI, QMCI, and
CQII). These statistical analyses were carried out in SAS
(version 9.3, SAS Institute Inc., NC, USA, 2001) [28].
Results
Seventy-four hospitals from seven countries provided valid
data. We analyzed 292 pathways. The hospital and pathway
characteristics are shown in Table 1.
Table 2 shows compliance with PSS by department together
with the average country range for each item. Over 90% of
patients were identified by wristband in 43.0% of AMI wards
(31/72), compared with 59.7% of maternity wards (43/72).
No significant differences between-department were observed
for compliance with patient identification recommendations,
but the differences between country averages were substantial,
with figures ranging from 0 to 91.7%. Recommendations such
as the use of needle disposal boxes and alcohol-based rubs
were met in over 85% of all departments, and the variability
between countries was lower (66.7–100.0%). Over two-thirds
of maternity wards still had potassium chloride concentrate
in their medication stocks, and the figures were even higher
in the other departments. AE reporting systems were available
in just one-third of the departments audited and reports were
used for quality of care evaluations in just half of these.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Characteristics of hospitals by care pathway
AMI
(n= 72)
Obstetric deliveries
(n= 72)
Hip fracture
(n= 74)
Stroke
(n= 74)
n (%) n (%) n (%) n (%)
Teaching hospital
Yes 32 (44.4) 33 (45.8) 33 (44.5) 33 (44.5)
No 40 (55.5) 39 (54.1) 41 (55.4) 41 (55.4)
Ownership
Public 59 (81.9) 58 (80.5) 59 (79.7) 59 (79.7)
Private or mixed 13 (18.0) 14 (19.4) 15 (20.2) 15 (20.2)
Number of beds
<200 7 (9.7) 6 (8.3) 7 (9.4) 7 (9.4)
200–500 21 (29.1) 22 (30.5) 22 (29.7) 22 (29.7)
500–1000 30 (41.6) 31 (43.0) 31 (41.8) 31 (41.8)
>1000 14 (19.4) 13 (18.0) 14 (18.9) 14 (18.9)
Teaching department status
Yes 39 (54.1) 42 45 (60.8) 40 (54.0)
No 33 (45.8) 30 29 (39.1) 34 (45.9)
AMI, acute myocardial infarction.
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Tables 3 and 4 show results for EBOP. Although a high
proportion of areas treating AMI patients (83.6%; country
range, 66.7–100%) have immediate, around-the-clock access
to a specialist physician to assess the need for coronary revas-
cularization, only 56.0% (country range, 18.2–85.7%) have
arrangements for patients to receive thrombolysis within 30
min of arrival at the hospital.
Findings for fast-track admission, timely intervention,
access to specialist skills, and diagnostic and treatment facilities
were similar for stroke and AMI patients. Screening of swal-
lowing by a specially trained healthcare professional in acute
stroke patients was limited (47.2%), with dramatic differences
in compliance (0–100%) between countries.
Delivery departments showed the best compliance with
EBOP, with prompt access to ultrasound facilities available in
all 72 departments. In one country, all 10 criteria analyzed
were met in all the hospitals, but in the other countries, fewer
than half of the departments complied with recommendations
regarding pain assessment, one-to-one midwifery care, and
screening for Rhesus disease.
Hip fracture departments showed the lowest overall compli-
ance with EBOP and also the highest between-country variabil-
ity. Six of the seven criteria assessed were not met in at least one
country, but were fully met in others. Where indicated, 61% of
departments (country range, 33.3–100%) perform hip surgery
within 48 h of admission.
Table 5 shows estimates for the covariance parameters from
the linear mixed models described above. In the case of PSS
(Model 1 of Table 5), after adjusting for pathway and hospital-
level predictors, country differences in our sample accounted
for 0% of the total variance. A larger amount of the total vari-
ance (65.9%) was explained by differences between hospitals
within countries.
Models 2–5 in Table 5 show variance decomposition results
for EBOP. For AMI, obstetric deliveries, and stroke, the pro-
portion of variance explained by between-country variation
was considerable, but less (10.1% in AMI, 40.0% in obstetric
deliveries, and 31.8% in stroke) than that explained by differ-
ences within countries. Between-country differences explained
a greater proportion of the variance of EBOP in the hip frac-
ture pathway (56.3%) compared with the other pathways.
Discussion
We assessed the implementation of PSS and EBOP and pos-
sible sources of variation in a large sample of European hospi-
tals. Our results indicate that neither PSS nor EBOP
recommendations are routinely followed and that there are
substantial differences between departments and hospitals.
Our findings raise serious concerns regarding the delivery of
optimal care and indicate substantial room for improvement.
Unfortunately, there is a scarcity of both literature on compli-
ance with PSS and EBOP recommendations in Europe and
comparable indicators. The criteria we used in our assessment
were based on guidelines from international expert groups and
on research findings and empirical evidence, which in many
cases, date back several years....
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Our results show that compliance with certain key recommen-
dations is far from ideal. Just one in three wards (in some coun-
tries, 1 in 10) have removed potassium chloride concentrate
solution from their general stocks, even though this practice was
recommended by the UK National Patient Safety Agency as
early as 2002 [29] and has since been advocated by many other
safety agencies. Other areas, in contrast, seem to have improved.
In a similar external ward evaluation conducted in 2007 in eight
EU countries, the percentage of wristband-identified patients in
medical and surgical wards was 22–30% [30]. In our study, 43.0–
59.7% of wards have over 90% of patients adequately identified.
While our figures indicate an improvement, they are still far
below the compliance rates that would be expected for such a
basic and crucial safety recommendation [31].
Prompt, timely intervention is a key component of the care
pathway in most conditions. In our study, only 56.0% of clinic-
al areas treating AMI patients (country range, 18.2–85.7%)
had verifiable arrangements for patients to receive thromboly-
sis within the recommended timeframe. While some EBOP
recommendations have been fully implemented in some
departments and hospitals, in others, they are scarcely visible.
The variations in the adoption of these recommendations are
similar to those reported for the uptake of research evidence
[32] and guidelines in clinical practice [33]. With the exception
of timely access to specialized diagnostic and treatment facil-
ities, most of the gaps identified in our study could be remed-
ied with minimum investment and simple strategies such as
wristband identification, removal of potassium chloride stocks,
or the implementation of swallowing screening protocols for
stroke patients. Barriers to implementation might include con-
flicting messages from different sources and a lack of informa-
tion in local languages. Additionally, poor compliance with
PSS and EBOP recommendations might be influenced by the
fact that they are not a legal or contractual requirement and
also perhaps by the fact that agencies advocating their imple-
mentation have overly focused on the passive dissemination of
knowledge, and ignored contextual factors that might facilitate
or hinder implementation [34].
In the area of patient safety, differences between hospitals
within a country accounted for a greater proportion of the
total variance (65.9%), while between-country differences
accounted for 0% of the total variance after adjusting for
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Compliance with evidence-based organization of care pathway recommendations for AMI and strokea
Item n (%), full
compliance
Average country
rangea (%)
Acute myocardial infarction departments (n= 66)
1. There are written criteria and procedures for fast-track admission and
treatment of patients presenting with acute chest pain
36 (54.5) 18.2–90.9
2. Arrangements ensure that eligible STEMI (S-Televation Myocardial Infarction)
patients can receive thrombolysis within 30 min of arrival at the hospital
37 (56.0) 18.2–85.7
3. Immediate access is available 24/7 to a specialist physician to determine
whether coronary revascularization is appropriate
57 (86.3) 66.7–100.0
4. Facilities are immediately available for performance of and transport for
emergency coronary angiography
48 (72.7) 40.0–90.9
5. Facilities are immediately available for performance of and transport for
percutaneous coronary intervention
44 (66.6) 36.4–81.8
Overall score, mean (SD) 3.2 (0.9)
Stroke departments (n= 74)
1. There is an agreed procedure for appropriate patients to be directly
transported by ambulance personnel to a stroke unit
42 (56.7) 36.4–100.0
2. Agreed procedures ensure that patients with suspected stroke are assessed
for receiving thrombolysis, if clinically indicated
55 (74.3) 41.7–100.0
3. A thrombolysis service is available 7 days a week in the hospital or by
formal arrangement elsewhere
62 (83.7) 58.3–100.0
4. Agreed procedures ensure that patients with acute stroke have their
swallowing screened by a specially trained healthcare professional
35 (47.2) 0.0–100.0
5. Protocols and procedures are available for patients to receive brain
imaging within 1 h of arrival at the hospital
46 (62.1) 25.0–91.7
6. Protocols are in place to ensure documented multidisciplinary goals
are agreed within 5 days of admission to hospital
31 (41.8) 8.3–66.7
7. There is immediate access (1 h) to a specialist acute stroke unit (or area)
for those with persisting neurological symptoms
51 (68.9) 50.0–83.3
Overall score, mean (SD) 3.0 (1.0)
aMinimum–maximum percentage of fully compliant hospitals by country used to determine country ranges.
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hospital-level predictors. Country-level compliance could be
similar, because of a possible direct effect on hospitals of
patient safety recommendations by international agencies, and
low influence by country policies. In the case of EBOP,
between-country differences play more important role and
explained at least 30% of the total variance for three of four
pathways. One possible explanation could be that EBOP is
linked to consensus statements issued by specialist groups that
are disseminated nationally through scientific meetings, country-
wide recommendations, etc. Variations between countries were
lower in areas where more level A evidence was available at the
time of the study (e.g. AMI).
Our study has some limitations. Our findings cannot be
generalized to the EU as a whole. Although random sampling
was performed in each country, the conclusions are not gener-
alizable because of our study design, the limited sample sizes
and substantial differences in the percentage of refusals from
one country to the next. It was not the aim of this study to
present findings that could be generalized or compared at the
country level, although such information would logically be of
interest to policymakers. Rather, given that all EU hospitals
potentially deliver services to all European citizens in the
context of cross-border care, we decided to explore potential
sources of variation in the measures. Here, again, sample size
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Table 4 Compliance with evidence-based organization of care pathway recommendations for obstetric deliveries and hip
fracturea
Item n (%), full
compliance
Average country range
(%)
Obstetric deliveries (n = 72)
1.A structured, accurate record of all events during the antenatal childbirth and
postnatal periods is maintained for every woman and child
66 (91.6) 58.3–100.0
2. All women who have epidural analgesia or an operative delivery have their pain
assessed using a pain assessment tool approved by the hospital
42 (58.3) 8.3–100.0
3. There is prompt access to ultrasound facilities with trained staff 72 (100) 100.0–100.0
4. There is a procedure that guarantees that all women who are identified in the
screening program as at risk of rhesus disease are properly managed
44 (61.1) 25.0–100.0
5. Each woman receives one-to-one midwifery care from a trained midwife during
established labor and childbirth
63 (87.5) 0.0–100.0
6. Epidural analgesia is available at all times 61 (84.7) 58.3–100.0
7. Adult intensive care facilities and specialist medical back-up are available onsite 70 (97.2) 90.9–100.0
8. Patient monitoring equipment and clinical expertise in its management are
available within the obstetric unit
71 (98.6) 91.7–100.0
9. There is a system in place to ensure that anesthetic and theater services respond
within 30 min to obstetric emergencies and expedite delivery in the event of maternal
or fetal compromise
69 (95.8) 83.3–100.0
10. All babies are clinically examined prior to discharge from hospital and/or
within 72 h of birth by a suitably qualified healthcare professional
71 (98.6) 90.9–100.0
Overall score, mean (SD) 3.7 (0.3)
Hip fracture (n= 74)
1. The guidelines require that medical staff assess patients suspected of having a
fractured hip within 1 h of arrival in the emergency department or of the incident if
the patient was already in hospital
27 (36.4) 0.0–75.0
2. The guidelines require a multidisciplinary assessment plan and individual goals
for rehabilitation to be documented within 24 h postoperatively
16 (21.6) 0.0–75.0
3. Magnetic resonance imaging (MRI) is immediately available if hip fracture is
suspected, despite negative plain X-rays
40 (54.0) 0.0–100.0
4. The guidelines require that all patients presenting with a fragility (pathological)
fracture are managed on a ward with routine access to orthogeriatric medical support
14 (18.9) 0.0–75.0
5. Whenever clinically appropriate, surgery is performed within 48 h of admission 45 (60.8) 33.3–100.0
6. Guidelines require that all patients undergoing hip fracture surgery receive
antibiotic prophylaxis
51 (68.9) 0.0–100.0
7. Guidelines require that, if the patient’s overall medical condition allows,
mobilization begins within 24 h postoperatively
28 (37.8) 0.0–75.0
Overall score, mean (SD) 2.3 (1.0)
aMinimum–maximum percentage of fully compliant hospitals by country used to determine country range.
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limitation could be important in the findings analysis because
it could contribute to unstable variance estimates. It should
also be noted that the instruments used to evaluate PSS and
EBOP are new and need further testing and refinement before
their widespread use can be recommended. We also did not
analyze inter-rater reliability, but potential bias from this
source was limited by organizing centralized training sessions
and using a limited number of auditors per country. Despite
the limitations of our study, we performed one of the largest
ever European studies and used an identical set of indicators
to measure PSS and EBOP across seven countries.
Regarding implications for policy, healthcare providers, pur-
chasers, and insurers should focus not only on bundles of care
but also on timing, as prompt delivery of care can optimize
both costs and benefits. Delays can be reduced through
investment in skills and equipment, adoption of triage and fast-
track strategies, and early transfer of patients to specialist
centers where indicated. In stroke patients, for instance, early
differentiation between ischemic and haemorrhagic causes is
critical to early intervention and faster recovery. In our study,
the structures required to grant this ‘window of opportunity’
were in place in just 62.1% of departments, and in some coun-
tries, this percentage was as low as 25%. Findings from the
Stroke Improvement National Audit Programme of the Royal
College of Physicians of London show that the percentage of
stroke patients receiving a brain scan within 24 h of admission
increased from 42% in 2006 to 90% in 2012 [35], demonstrat-
ing that changes in hospital practices can clearly benefit patients.
Making PSS and EBOP recommendations, department require-
ments could help to improve the situation in many areas.
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Table 5 Country- and hospital-level variances (as percentages of the total variance) of PSS and evidence-based organization of
the care pathway (EBOP) scores
Between-country
variability
Within-country
(between-hospital)
variability
Within-hospital
(between-department)
variability
Total
variance
Variance (%) Variance (%) Variance (%)
aModel 1. PSS modeled as a function of
pathway, hospital-level quality
implementation, ownership status, teaching
status, and size of hospitals with random
intercepts for country and hospital nested
within country
0 (0) 0.1827 (65.9) 0.0943 (34.1) 0.2770
bModel 2. AMI-EBOP modeled as a function
of hospital-level quality implementation,
ownership status, teaching status, and size of
hospitals with random intercepts for country
and hospital nested within country
0.0685 (10.1) 0.6127 (89.9) N.A. 0.6812
bModel 3. STROKE-EBOP modeled as a
function of hospital-level quality
implementation, ownership status, teaching
status, and size of hospitals with random
intercepts for country and hospital nested
within country
0.3078 (31.8) 0.6603 (68.2) N.A. 0.9681
bModel 4.OBSTETRIC
DELIVERIES-EBOP modeled as a function
of hospital level quality implementation,
ownership status, teaching status, and size of
hospitals with random intercepts for country
and hospital nested within country
0.0557 (40.0) 0.0835 (60.0) N.A. 0.1392
bModel 5. HIP FRACTURE-EBOP modeled
as a function of hospital-level quality
implementation, ownership status, teaching
status, and size of hospitals with random
intercepts for country and hospital nested
within country
0.7226 (56.3) 0.5611 (43.7) N.A. 1.2837
aLinear mixed regression with random intercept by country and hospital nested within country, and fixed effects for pathway, hospital-level
quality implementation (QMSI, QMSCI, CQII), and hospital characteristics (number of beds, hospital ownership, hospital teaching status).
bLinear mixed regression by pathway with random intercept by country, and fixed effects for hospital-level quality implementation (QMSI,
QMSCI, CQII) and hospital characteristics (number of beds, hospital ownership, hospital teaching status).
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The EU directive on cross-border healthcare [13] requires
member states of treatment (where cross-border healthcare is
provided) to develop quality and safety standards and guide-
lines but allows member states of affiliation (where patients are
insured) to refuse authorization for treatment in another
country for a number of reasons, including exposure ‘with rea-
sonable certainty to a patient-safety risk that cannot be
regarded as acceptable’. There is no definition of acceptable
risk, but evidence of failure to adopt well-evidenced guidelines
on systems to protect patients may offer legitimate grounds for
denial of authorization. In our study, 224 (83%) of the 292
departments would be considered ‘unsafe’ if removal of potas-
sium chloride concentrate from general ward stocks was con-
sidered essential, and in the case of wristband identification,
140 departments (48%) would not pass the test.
The fact that country differences seem to play a minor role
in explaining the variations observed in the implementation of
PSS has important policy consequences for EU member states
because, at least based on our findings, there are no indications
that citizens have a better chance of receiving safer care
outside their country. In the case for EBOP, country differ-
ences account for more than one-third of variation in three
conditions, but within-country differences were the main
source of variation, except for hip fracture. This has also im-
portant consequences when patients seek for care outside of
their country. These findings highlight the importance of com-
piling public data on the extent of implementation of PSS and
EBOP to help citizens to choose hospitals not only outside
their country of origin but also within their own country.
Conclusions
This study shows significant gaps between knowledge and prac-
tice of patient safety and evidence-based organization in a sample
of European hospitals. Our findings have implications for both
policy and individual welfare as they suggest that a substantial
proportion of European citizens are at risk of receiving subopti-
mal care and compliance with PSS and EBOP varied consider-
ably from one hospital to the next in the same country and less
between countries. Citizens need to be informed of these varia-
tions and to understand the importance of having access to infor-
mation on hospital and department compliance with PSS and
EBOP recommendations both inside and outside their countries.
Direct comparisons were not feasible in our study because of the
small sample sizes, but future research could focus on compara-
tive analysis and explore in greater depth the causes of variability
within regions, states, and even across borders.
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